IMC Chicago’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
IMC Chicago's ASND Position: Q1 2026 in Review
IMC Chicago sold out of Ascendis Pharma (ASND) in Q1 2026, closing a stake of 113,682 shares — an estimated $25.5M sold.
IMC Chicago first reported a position in ASND in Q4 2025 and held it in 1 quarter. The position peaked at $24.2M in Q4 2025. 278 funds tracked by Wall St. Rank hold ASND as of Q1 2026.
- IMC Chicago reported no remaining Ascendis Pharma position as of Q1 2026 after selling out during the quarter.
- IMC Chicago sold 113,682 Ascendis Pharma shares in Q1 2026, an estimated $25.5M.
- IMC Chicago first reported a position in Ascendis Pharma in Q4 2025 and held it in 1 quarter.
- IMC Chicago's Ascendis Pharma position peaked at $24.2M in Q4 2025.
- 278 funds tracked by Wall St. Rank held Ascendis Pharma as of Q1 2026.
Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.